Gsa Capital Partners LLP Procept Bio Robotics Corp Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 6,659 shares of PRCT stock, worth $257,037. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,659Holding current value
$257,037% of portfolio
0.03%Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
296Shares Held
44.6MCall Options Held
283KPut Options Held
144K-
Vanguard Group Inc Valley Forge, PA5.25MShares$203 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$135 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$83.3 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$59 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$51 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...